We are live on ! Find out more
CCP

Clough Capital Partners Portfolio holdings

AUM $1.23B
1-Year Est. Return 51.32%
This Fund
S&P 500
This Quarter Est. Return
+12.69%
1 Year Est. Return
+51.32%
3 Year Est. Return
+175.14%
5 Year Est. Return
+243.7%
10 Year Est. Return
+1,533.05%
AUM
$1.39B
AUM Growth
+$369M
Cap. Flow
+$119M
Cap. Flow %
8.56%
Top 10 Hldgs %
35.51%
Holding
159
New
28
Increased
42
Reduced
24
Closed
36

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$42M
2
META icon
Meta Platforms (Facebook)
META
+$23M
3
CMPI
Checkmate Pharmaceuticals, Inc. Common Stock
CMPI
+$16.8M
4
BAX icon
Baxter International
BAX
+$14.9M
5
TSM icon
TSMC
TSM
+$14.3M

Top Sells

Rank Stock Value
1
NFLX icon
Netflix
NFLX
+$22.6M
2
TMUS icon
T-Mobile US
TMUS
+$15.6M
3
SBAC icon
SBA Communications
SBAC
+$15.3M
4
SHOP icon
Shopify
SHOP
+$15.1M
5
AMZN icon
Amazon
AMZN
+$14.7M

Sector Composition

Rank Sector Weight
1 Healthcare 28.32%
2 Financials 19.81%
3 Technology 14.82%
4 Miscellaneous 14.64%
5 Consumer Discretionary 11.36%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TMO icon
26
Thermo Fisher Scientific
TMO
$237B
$18.8M 1.35%
42,473
+5,090
+14% +$2.1M
TDOC icon
27
Teladoc Health
TDOC
$1.2B
$18.7M 1.34%
85,214
+14,210
+20% +$3.01M
GWPH
28
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
$18.6M 1.34%
190,716
+89,970
+89% +$10.4M
LH icon
29
Labcorp
LH
$26.3B
$17.7M 1.27%
109,160
+59,969
+122% +$9.5M
ONEM
30
DELISTED
1Life Healthcare
ONEM
$15.9M 1.14%
561,100
+346,400
+161% +$10.9M
CMPI
31
DELISTED
Checkmate Pharmaceuticals, Inc. Common Stock
CMPI
$14.9M 1.07%
+1,313,286
New +$16.8M
BAX icon
32
Baxter International
BAX
$12.3B
$14.3M 1.03%
+177,300
New +$14.9M
ZLAB icon
33
Zai Lab
ZLAB
$2.78B
$14.2M 1.02%
171,220
+22,300
+15% +$1.79M
TSLX icon
34
Sixth Street Specialty
TSLX
$1.7B
$14.2M 1.02%
823,627
+9,600
+1% +$164K
GBDC icon
35
Golub Capital BDC
GBDC
$3.23B
$14.1M 1.02%
1,068,625
– –
MA icon
36
Mastercard
MA
$502B
$13.4M 0.96%
39,669
+12,790
+48% +$4.16M
DOC
37
DELISTED
PHYSICIANS REALTY TRUST
DOC
$13.2M 0.95%
738,900
+66,800
+10% +$1.19M
QRVO icon
38
Qorvo
QRVO
$10.4B
$13.1M 0.94%
101,740
+35,140
+53% +$4.36M
REGN icon
39
Regeneron Pharmaceuticals
REGN
$79.7B
$13M 0.94%
23,292
-5,823
-20% -$3.53M
FLXN
40
DELISTED
Flexion Therapeutics, Inc.
FLXN
$13M 0.93%
1,246,150
+207,700
+20% +$2.55M
V icon
41
Visa
V
$701B
$12.5M 0.9%
62,480
+21,020
+51% +$4.2M
APLS
42
DELISTED
Apellis Pharmaceuticals
APLS
$12.2M 0.88%
405,834
– –
ARCC icon
43
Ares Capital
ARCC
$13.9B
$12.2M 0.88%
+877,300
New +$12.5M
CCL icon
44
Carnival Corporation Ltd
CCL
$30.3B
$12M 0.86%
791,340
+388,600
+96% +$6.01M
BBDC icon
45
Barings BDC
BBDC
$914M
$12M 0.86%
1,494,826
+278,446
+23% +$2.21M
MRTX
46
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$11.3M 0.81%
68,170
-61,790
-48% -$8.46M
MCK icon
47
McKesson
MCK
$105B
$11M 0.79%
+73,730
New +$11.2M
ABBV icon
48
AbbVie
ABBV
$465B
$10.9M 0.78%
+124,300
New +$11.7M
LRCX icon
49
Lam Research
LRCX
$339B
$9.87M 0.71%
297,500
– –
SWKS icon
50
Skyworks Solutions
SWKS
$13.5B
$9.3M 0.67%
+63,920
New +$8.89M
1
2
3 4 5

Similar funds

ACG
Allen Capital Group Grand Island, Nebraska $1.23B AUM 19.04% 1-Year Est. Return
MAA
Matrix Asset Advisors White Plains, New York $1.23B AUM 26.4% 1-Year Est. Return
CCFCSB
Cape Cod Five Cents Savings Bank Orleans, Massachusetts $1.23B AUM
SCP
Sandhill Capital Partners Buffalo, New York $1.23B AUM 13.7% 1-Year Est. Return
OA
Oxbow Advisors Austin, Texas $1.23B AUM 23.59% 1-Year Est. Return
RIM
Rockbridge Investment Management Syracuse, New York $1.23B AUM 15.23% 1-Year Est. Return
ZA
Zazove Associates Incline Village, Nevada $1.22B AUM 1.92% 1-Year Est. Return
WVUF
West Virginia University Foundation Morgantown, West Virginia $1.22B AUM 21.82% 1-Year Est. Return

Clough Capital Partners's Q3 2020 Portfolio in Review

As of Q3 2020, Clough Capital Partners held 159 positions worth $1.39B, up 36% from $1.02B the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Clough Capital Partners deployed $119M of net new capital in Q3 2020, opening 28 new positions and adding to 42 existing holdings. Its largest new stake was Meta Platforms (Facebook): 89,145 shares worth $23.3M.

By sector, the portfolio is most concentrated in Healthcare at 28% of assets, up from 24% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was T-Mobile US, an estimated $15.6M trimmed.

  • Clough Capital Partners's largest Q3 2020 buy was Meta Platforms (Facebook): 89,145 shares worth $23.3M.
  • Clough Capital Partners added most to Apple in Q3 2020, an estimated $42M increase.
  • Clough Capital Partners's biggest Q3 2020 reduction was T-Mobile US, cutting an estimated $15.6M.
  • Clough Capital Partners fully exited Netflix in Q3 2020, selling an estimated $22.6M.
  • Clough Capital Partners's ten largest holdings make up 36% of its $1.39B portfolio in Q3 2020.
  • Clough Capital Partners opened 28 new positions and closed 36 in Q3 2020.
  • Clough Capital Partners's portfolio value rose 36% quarter-over-quarter to $1.39B.

Based on Clough Capital Partners's 13F filing for Q3 2020, filed 17 Nov 2020.